dihydroisoperparine,
drotaverin,
drotaverin hydrochloride,
drotaverine,
isodihydroperparine,
No-shpa,
No-spa,
Nospan,
Nospanum,
Tetraspasmin-Lefa,
DROTAVERINE HYDROCHLORIDE,
985-12-6,
Drotaverin hydrochloride,
No-Spa hydrochloride,
Drotaverinium chloride,
DROTAVERINE HCL,
No-Spa,
Drotin,
UNII-24ZVH4C669,
C24H31NO4.HCl,
24ZVH4C669,
Isodihydroperparine hydrochloride,
6,7,3',4'-Tetraethoxy-1-benzal-1,2,3,4-tetrahydroisoquinoline hydrochloride,
Isoquinoline, 1-(3,4-diethoxybenzylidene)-6,7-diethoxy-1,2,3,4-tetrahydro-, hydrochloride,
Isoquinoline, 1,2,3,4-tetrahydro-6,7-diethoxy-1-((3,4-diethoxyphenyl)methylene)-, hydrochloride,
Drotaverin HCl,
(Z)-1-(3,4-Diethoxybenzylidene)-6,7-diethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride,
(1Z)-1-[(3,4-diethoxyphenyl)methylidene]-6,7-diethoxy-3,4-dihydro-2H-isoquinoline,hydrochloride,
Isoquinoline, 1-((3,4-diethoxyphenyl)methylene)-6,7-diethoxy-1,2,3,4-tetrahydro-, hydrochloride,
Taverin (TN),
AC1O5OJF,
MLS003882593,
ARONIS24453,
SCHEMBL159355,
SCHEMBL159356,
BBC/617,
DTXSID40243590,
ZX-AS004818,
AKOS015962141,
AC-15901,
AN-48198,
Drotaverine HCl ;1-[(3,4-Diethoxyphenyl)methylene]-6,7-diethoxy 1,2,3,4-tetrahydroisoquinoline HCL,
K767,
LS-85887,
SMR002530129,
Drotaverine hydrochloride, >=95% (HPLC),
TL8000901,
(1Z)-1-[(3,4-diethoxyphenyl)methylidene]-6,7-diethoxy-3,4-dihydro-2H-isoquinoline hydrochloride,
D07879,
985D126,
F0001-2381,
(1Z)-1-[(3,4-diethoxyphenyl)methylene]-6,7-diethoxy-3,4-dihydro-2H-isoquinoline hydrochloride,
Isoquinoline, 1,2,3,4-tetrahydro-6,7-diethoxy-1-((3,4-diethoxyphenyl)methylene)-,hydrochloride,
C24-H31-N-O4.Cl-H,
CID6437861,
14009-24-6,
Isoquinoline, 1-[(3,4-diethoxyphenyl)methylene]-6,7-diethoxy-1,2,3,4-tetrahydro-, hydrochloride,